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Antioxidant enzymesThe aim of this study was to investigate the effects of dietary conjugated linoleic acid (CLA) and phytosterol
supplementation and their combination on antioxidant enzyme activities and biomarkers of lipid peroxida-
tion in healthy rats. Forty male Sprague–Dawley rats were divided into ﬁve groups and received diets
supplemented with 2% of soybean oil (group S), safﬂower oil (group LA) (control), a mixture of c9,t11 and
t10,c12 CLA (group CLA), phytosterols (group P) and a mixture of CLA and phytosterols (group CLA+P) for
9 weeks. Plasma and hepatic indicators of lipid autoxidation and plasma antioxidant enzymes activities
were determined. The supplementation with the mixture of CLA and phytosterols (CLA+P) did not alter
food intake, weight gain, plasma malondialdehyde (MDA) and glutathione (GSH) values, superoxide
dismutase (SOD), glutathione peroxidase (GPx) and glutathione reductase (GRd) activities (P>0.05). The
supplementation with CLA signiﬁcantly increased plasma catalase (CAT) activity (3.7-fold) and plasma
8-isoprostane values (60%) compared to S group (Pb0.05). However, the association between CLA and
phytosterols was able to restore the CAT and 8-isoprostane levels to basal values, since these indicators in
the CLA+P group were statistically similar to S group. CLA+P supplementation also decreased lipid peroxida-
tion primary (58%) and secondary (52%) products in liver (Pb0.05). Supplementation of isolated phytosterols
and CLA was also able to reduce hepatic lipid peroxidation products and plasma levels of MDA (Pb0.05). The
dietary combination of CLA+P improved the antioxidant status, reduced the lipid peroxidation and protected
against possible effects of CLA supplementation on oxidative stress in vivo.
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evier OA license.rumen (Pariza, Park, & Cook, 2001). They are found in small amounts
in a large variety of foods, like in meats and dairy products and the
most abundant isomer is the cis-9, trans-11-CLA (c9,t11) (Chin, Liu,
Storkson, Ha, & Pariza, 1992; Kepler, Hirons, McNeill, & Tove, 1966).
Commercial preparations of CLA are made of linoleic acid from
safﬂower or sunﬂower oils under alkaline conditions and are usually
a 1:1 mixture of c9,t11 and trans-10, cis-12 (t10,c12) CLA with other
isomers in minor concentrations (Pariza et al., 2001).
Several studies have shown the biological effects of CLA isomers,
including anticarcinogenic properties, body composition change,
prevention of atherosclerosis, enhancement of bone mineralization,
immune system modulation and improvement of insulin resistance
(Bhattacharya, Banu, Rahman, Causey, & Fernandes, 2006; Park,
2009). It has been also reported that CLA protects against oxidative
stress and lipid peroxidation in animal models (Cantwell, Devery,
O'shea, & Stanton, 1999; Ip, Chin, Scimeca, & Pariza, 1991; Kim et al.,
2005; Moon et al., 2009). On the other hand, adverse effects of CLA sup-
plementation have also been studied, particularly regarding increased
susceptibility to lipid autoxidation (Basu, Risérus, Turpeinen, &
Vessby, 2000; Basu, Smedman, & Vessby, 2000; Risérus, Vessby,
Ärnlöv, & Basu, 2004; Yamasaki et al., 2000). However, metabolic
effects of CLA in animals are divergent, not completely elucidated, and
Table 1
Fatty acid proﬁles of lipid supplements used to prepare the experimental diets.a.
Fatty acids Soybean oil Safﬂower oil CLA
Tonalin®b
Phytosterol
Vegapure® 95FF
C6:0 – 0.03 0.04 –
C8:0 – 0.03 0.04 –
C10:0 – – 0.04 –
C12:0 – 0.03 0.04 –
C14:0 0.08 0.10 0.04 –
C15:0 0.03 0.03 – –
C16:0 10.66 6.26 1.86 6.62
C16:1 0.09 0.08 – –
C17:0 0.09 0.05 0.05 –
C17:1 0.06 0.03 0.04 –
C18:0 3.19 2.29 2.84 3.00
C18:1 28.53 13.17 13.86 23.26
C18:2 trans – 0.13 0.44 –
C18:2 50.56 76.62 0.32 66.13
C18:2 t10c12 – – 40.25 –
C18:2 c9t11 – – 40.14 –
C18:3 trans 0.43 – – –
C18:3 5.02 0.10 – –
C20:0 0.35 0.33 – –
C20:1 0.25 0.18 – –
C22:0 0.49 0.23 – –
C22:1 – 0.04 – –
C24:0 0.17 0.12 – –
C24:1 – 0.18 – –
Total 100 100 100 100
a Data are expressed as relative percentages of total methyl esters.
b CLA: conjugated linoleic acid. The CLA was 80% pure, and it contained 50% c9,t11
and 50% t10,c12.
Table 2
Phytosterol proﬁles of lipid supplements used to prepare the experimental diets.
Components (%) Soybean
oil
Safﬂower
oil
CLA
Tonalin®a
Phytosterol
Vegapure® 95FF
Cholesterol 0.38 0.00 14.15 0.52
Cholestanol (PI) – – – –
Brassicasterol 0.00 0.00 0.00 0.00
24-metilencholesterol 0.00 0.00 0.00 0.00
Campesterol 16.92 10.51 22.05 29.59
Campestanol 1.10 0.65 13.15 0.79
Estigmasterol 18.58 4.62 12.83 19.42
Δ 7-campesterol 0.00 0.00 0.00 0.00
Δ 5,23-estigmastadienol 1.28 4.54 0.00 0.87
Clerosterol 0.83 0.58 0.00 0.59
β-sitosterol 50.80 44.33 37.82 44.88
Sitostanol 2.71 3.41 0.00 2.38
Δ 5-avenasterol 0.30 2.48 0.00 0.00
Δ 5,24-estigmastadienol 0.35 1.44 0.00 0.57
Δ 7-estigmastenol 4.7 23.27 0.00 0.39
Δ 7-avenasterol 2.05 4.17 0.00 0.00
Total 100 100 0.00 100
Phytosterols (g/100 g) 0.29 0.30 0.006 50.53
a CLA: conjugated linoleic acid.
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lipid oxidation.
Phytosterols (plant sterols) are bioactive components of all vege-
table foods. In plants, more than 200 different types of phytosterols
have been reported and the principal plant sterols are β-sitosterol
(24-α-ethylcholesterol), campesterol (24-α-methylcholesterol) and
stigmasterol (Δ22, 24-α-ethylcholesterol) (Moreau, Whitaker, &
Hicks, 2002). They have been shown to be effective, and no adverse
effects have been observed when added to foodstuffs, furthermore,
they are listed as GRAS (Generally Recognized as Safe) by the Food
and Drug Administration for the general population (Hicks &
Moreau, 2001; Kritchevsky & Chen, 2005).
They have been used as blood cholesterol‐lowering agents for the
last half century and the effect of these compounds on plasma lipid
levels has been tested in animals and humans (Jong, Plat, &
Mensink, 2003; Moghadasian & Frohlich, 1999). Although most stud-
ies have focused on the hypocholesterolemic activity of phytosterols,
other biological properties such as antioxidant activity have also been
attributed to these plant compounds in foods, animal models and
human studies (Fuhrman, Plat, Herzog, & Aviram, 2007; Mannarino
et al., 2009; Summanen et al., 2003; Wang, Hicks, & Moreau, 2002).
It has been postulated that a network of antioxidants with different
chemical properties maywork in a synergistic way, protecting cells and
tissues from damage (Jacobs & Steffen, 2003). Recently, it was shown
that the combination of CLA and natural compounds from marine
plant extracts could exert beneﬁcial effects related to lipid metabolism
in obese rats (Hu et al., 2012).
In view of a possible pro-oxidant action of CLA (as it is a conjugated
diene), its supplementation in association with the antioxidant protec-
tion could minimize the deleterious action of CLA on the process of
biological lipid oxidation. Thus, the aim of the present study was to in-
vestigate the effect of CLA and phytosterol supplementation, alone or in
combination, on the process of lipid autoxidation and in antioxidant
enzyme activities in healthy Sprague–Dawley rats.
2. Materials and methods
2.1. Supplements
Safﬂower oil, CLA Tonalin® and phytosterol Vegapure® 95FF were
supplied by Cognis Brasil Ltda.
2.1.1. Determination of fatty acid proﬁles of lipid supplements
The fatty acid compositions of the different lipid supplements
(soybean oil, safﬂower oil, CLA and phytosterols) were determined
by gas chromatography (GC) (Kramer et al., 1997) using a capillary
GC Agilent 6850 Series GC System, capillary column DB-23 Agilent
(50% cyanopropyl‐methylpolysiloxane, 60 m x 0.25 mm×0.25 μm);
helium was used as carrier gas. Sample methylation and esteriﬁcation
were performed as described by Maia and Rodriguez-Amaya (1993).
Fatty acid methyl esters of the samples were identiﬁed by the com-
parison of their relative retention times with those of commercial
standard esters under the same conditions. The fatty acid proﬁle of
lipid supplements is presented in Table 1. The percentages of each
lipid compound of interest were used to calculate the exact amount
used on the diets.
2.1.2. Phytosterols analysis
The identiﬁcation and quantiﬁcation of phytosterols in lipid supple-
ments (soybean oil, safﬂower oil, CLA and phytosterols) were
performed by GC (Becker, Gonçalves, Grimaldi, & Fernandes, 2005)
using a GC Agilent 6850 Series GC System equippedwith automatic injec-
tor, FID detector, software Agillent Chemstation Plus, versionA.08xx and a
fused silica capillary column LM 5 (5% fenil 95% metilpolisiloxane,
30 m×0.25 mm×0.3 μm). The phytosterol proﬁle of lipid supplementsis presented in Table 2. The percentage of total phytosterol was used to
calculate the exact amount used on the diets.
2.2. Animals and diets
This work was approved by the Ethics Commission on Animal Use
(CEUA–IB/UNICAMP, Protocol no. 2296-1) and followed the University
guidelines for the use of animals in experimental studies. Forty healthy
male Sprague–Dawley rats aged from 21 to 23 days were obtained from
the Multidisciplinary Center for Biological Investigation, University
of Campinas. AIN-93G diet was prepared monthly according to the
American Institute of Nutrition (Reeves, Nielsen, & Fahey, 1993), with
a protein concentration of 12% (Goena et al., 1989). The soybean oil is
the recommended source of fat in the AIN-93 diets, so it was used as
a standard source of lipids. The chemically synthesized CLA from
489R.S. Marineli et al. / Food Research International 49 (2012) 487–493safﬂower oil was added to the diets, which is rich in linoleic acid
(76.62%), so the safﬂower oil was used as a control fatty acid, which
is in accordance with Yamasaki et al. (2000). Diet was packed in dark
polyethylene bags and stored at −20 °C to minimize the oxidation of
fatty acids. Animals remained in individual cages for 9 weeks, including
an adaptation period of 7 days, with free access to water and feed and
maintained in a temperature controlled room (22±1 °C, 60–70%
humidity), using 12 h light/dark cycle. Animals were randomly divided
in ﬁve experimental groups (n=8/group) that received diet
supplemented with 2% of the compound of interest in each lipid
supplement: group S received diet supplemented with soybean oil
(as a standard source of lipids); group LA received diet supplemented
with safﬂower oil (as a control fatty acid); group CLA received diet
supplementedwith CLA Tonalin®; group P received diet supplemented
with phytosterol Vegapure® 95FF; and group CLA+P received diet
supplemented with a mixture of CLA and phytosterols. The weight
gain was monitored weekly and the food intake was monitored every
2 days during the experimental period. The diets' compositions are
presented in Table 3.
2.2.1. Blood and tissue collection for biochemical analysis
The animals were sacriﬁced by decapitation preceded by 12-hour-
fasting after 9 weeks of the experimental period. Blood samples were
collected in polyethylene tubes with anticoagulant EDTA to obtain
plasma. Tubes were centrifuged at 4 °C (3000 rpm for 15 min). After
that, supernatant plasma was separated, and stored in polypropylene
microtubes at −80 °C until analysis. Liver was removed, weighed,
frozen in liquid nitrogen and after that stored at−80 °C for subsequent
analysis.
2.2.2. Plasma antioxidant enzymes activities and biomarkers of lipid
peroxidation
Commercial kits from Cayman Chemical (Ann Arbor, MI, USA)
were used to determine plasma levels of malondialdehyde (MDA,
10009055), glutathione (GSH, 703002), catalase (CAT, 707002),
superoxide dismutase (SOD, 706002), glutathione peroxidase (GPx,
703102) and glutathione reductase (GRd, 703202). 8-Isoprostane
(516351)was determined by an enzyme immunoassay kit from Cayman
Chemical (Ann Arbor, MI, USA).
2.2.3. Hepatic lipid autoxidation products and total lipid analysis
After euthanasia, liver was lyophilized, milled, and stored at−80 °C
for subsequent analysis. For the determination of the hepatic peroxide
index (primary lipid autoxidation product), lipids were previouslyTable 3
Composition of the experimental diets (g/kg).
Ingredient S LA CLA P CLA+P
Casein (78% protein)a 153.24 153.24 153.24 153.24 153.24
Corn starch 427 427 427 427 427
Maltodextrin 141.8 141.8 141.8 141.8 141.8
Sucrose 107.43 107.43 107.43 107.43 107.43
Soybean oil 90 70 70 70 70
Cellulose 50 50 50 50 50
Mineral mixb 35 35 35 35 35
Vitamin mixb 10 10 10 10 10
L-cystine 3 3 3 3 3
Choline bitartrate 2.5 2.5 2.5 2.5 2.5
Tert-butyl hydroquinone 0.014 0.014 0.014 0.014 0.014
Phytosterol Vegapure® 95FF – – – 40 40
Safﬂower oil – 26.1 – – –
CLA Tonalin® – – 25.3 – 25.3
a To provide 12 g of protein/100 g of diet.
b Vitamin and mineral mixtures were prepared according to Reeves et al. (1993). S:
diet supplemented with soybean oil, LA: diet supplemented with safﬂower oil, CLA:
diet supplemented with conjugated linoleic acid (CLA), P: diet supplemented with
phytosterols and CLA+P: diet supplemented with conjugated linoleic acid and
phytosterols.extracted from lyophilized liver samples of each animal by the method
of the Bligh and Dyer (1959) extractionwith somemodiﬁcations due to
sample peculiarities. After lipid extraction, peroxide index determina-
tion was performed according to the Association of Ofﬁcial Analytical
Chemists (AOAC, 2000). For the determination of the peroxide index,
the amount of lipids present in the chloroform solution resulting from
the lipid extraction procedure of Bligh and Dyer (1959) extraction
was used. For the determination of the hepatic thiobarbituric acid reac-
tive substances (TBARS — secondary lipid autoxidation product), the
method proposed by Sinnhuber and Yu (1958) was used. The method
is based in the formation of a pink-red pigment composed of 2 mole-
cules of thiobarbituric acid and 1 of MDA. Results are expressed as mg
MDA/kg liver weight.
2.3. Statistical analysis
Data are expressed as mean values±S.E.M. Differences among the
groups (S, LA, CLA, P and CLA+P) were tested by one-way analysis
of variance (ANOVA) followed by Tukey's test using Statistical Analysis
System 9.1.3 software (SAS, 2003). P≤0.05 was considered statistically
signiﬁcant.
3. Results
Animals looked healthy during the study and tolerated well the
supplemented diets. Cumulative feed intake was statistically (Pb0.05)
lower in CLA group compared to P group, but cumulative body weight
gain was similar in all groups (P>0.05) (Table 4).
The CLA supplementation signiﬁcantly increased 3.7 times plasma
CAT activity (Fig. 1.A) and 60% plasma 8-isoprostane values (Fig. 1.B)
compared to S group (Pb0.05). In addition, the association between
CLA and phytosterols was able to restore the CAT and 8-isoprostane
levels to basal values, since these indicators in the CLA+P group
were statistically similar to S group.
There was no signiﬁcant difference among the experimental groups
for plasma GSH level, GRd and GPx activities (P>0.05) (Fig. 1.C, D, E).
CLA and P groups showed the lowest (15.16±1.23 U/mL) and the
highest (23.38±2.33 U/mL) plasma SOD activity, respectively
(Pb0.05). CLA+P group showed SOD values similar to S group
(Fig. 1.F).
LA, CLA and P groups showed a signiﬁcant reduction on plasma
MDA levels (48%) (Pb0.05) compared to S group (Fig. 1.G).
The supplementation with CLA (CLA group), phytosterols (P group)
and their mixture (CLA+P group) showed a signiﬁcant (Pb0.05) re-
duction on hepatic MDA levels (52%), compared to S and LA groups
(Fig. 2.A). Furthermore, CLA and P groups showed a signiﬁcant
(Pb0.05) reduction on hepatic peroxide index, 25% and 48% compared
to S group, respectively, but the combination of the supplements
(CLA+P group) was more efﬁcient and reduced peroxide index levels
about 58% compared to S group (Fig. 2.B).Table 4
Cumulative body weight gain and cumulative food intake in rats fed S, LA, CLA, P and
CLA+P diets A.
Variables S LA CLA P CLA+P
Cumulative weight
gain (g)
89.82±
3.26
91.51±
3.96
87.70±
2.30
92.03±
5.72
101.77±
4.90
Cumulative
food intake (g)
469.98±
26.91ab
480.31±
22.52ab
446.66±
19.24b
515.13±
26.11a
492.35±
23.57ab
AS: group receiving diet supplemented with soybean oil, LA: group receiving diet
supplemented with safﬂower oil, CLA: group receiving diet supplemented with
conjugated linoleic acid (CLA), P: group receiving diet supplemented with phytosterols,
and CLA+P: group receiving diet supplemented with conjugated linoleic acid plus
phytosterols. Values expressed as means±S.E.M., n=8/group. a,bMeans followed by
different letters in the same line indicate statistical differences by one-way analysis of
variance followed by Tukey's test (P≤0.05).
Fig. 1. Plasma levels of catalase (CAT) (A), 8-isoprostane (B), GSH (glutathione) (C), GRd (glutathione reductase) (D), GPx (glutathione peroxidase) (E), SOD (superoxide
dismutase) (F) and malondialdehyde (MDA) (G) in Sprague–Dawley rats fed supplemented diets containing soybean oil (S), safﬂower oil (LA), conjugated linoleic acid (CLA), phy-
tosterols (P) and conjugated linoleic acid with phytosterols (CLA+P) for 9 weeks. Data are expressed as mean±S.E.M.; n=8/group. a,bValues with different letters indicate signif-
icant difference by one-way analysis of variance followed by Tukey's test (P≤0.05).
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An imbalance in oxygen levels causes the generation of reactive
oxygen species (ROS), which promote oxidative stress by damaging
macromolecules, contributing to the pathologies of Alzheimer's dis-
ease, Parkinson's disease and atherosclerosis (Kulkarni, Kuppusamy,
& Parinandi, 2007). A depletion of antioxidant defenses can also tip
the ROS antioxidant balance and cause oxidative stress (Sies, 1991).
Antioxidant based products (drug formulations or plant extracts)
are used for the prevention and treatment of complex diseases likediabetes, cardiovascular and neurodegenerative diseases and cancer
(Noonan, Benelli, & Albini, 2007).
Our data show that the animals supplemented with CLA isomers
mixture (c9,t11 and t10,c12) showed an increase in plasma
8-isoprostane levels, suggesting that CLA could act as pro-oxidant
agent. The 8-isoprostane is a speciﬁc product of lipid peroxidation
formed in vivo via a non-enzymatic mechanism involving the free
radical-catalyzed peroxidation of arachidonic acid (AA) and is the
most speciﬁc biological indicator for the assessment of oxidative
stress in vivo (Musiek, Yin, Milne, & Morrow, 2005).
Fig. 2. Hepatic malondialdehyde (MDA) (A) and peroxide index (B) in Sprague–Dawley
rats fed supplemented diets containing soybean oil (S), safﬂower oil (LA), conjugated
linoleic acid (CLA), phytosterols (P) and conjugated linoleic acid with phytosterols
(CLA+P) for 9 weeks. Data are expressed as mean±S.E.M.; n=8/group. a,b,cValues
with different letters indicate signiﬁcant difference by one-way analysis of variance
followed by Tukey's test (P≤0.05).
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activated receptors (PPAR), like PPARα. Therefore any change in its
activity may inﬂuence 8-isoprotane concentration. CLA is preferentially
β-oxidized in peroxisomes and also avid ligand of PPARα, as shown by
Moya-Camarena, Heuvel, Blanchard, Leesnitzer, and Belury (1999),
which may compete with 8-isoprostane, leading to a decrease in their
products formation, and might explain the increase of 8-isoprostane
during CLA supplementation (Iannone et al., 2009).
Many studies aimed to assess the oxidative stress by determination
of 8-isoprostane in different experimental models, including humans.
Basu, Smedman, and Vessby (2000) studied the CLA supplementation
in healthy humans for 12 weeks. They found urinary and plasma
8-isoprostane values signiﬁcantly higher than the control group, and
categorically stated that CLA induces lipid peroxidation in humans.
Basu, Risérus, Turpeinen, and Vessby (2000) also demonstrated that
CLA supplementation for only one month was enough to induce a sig-
niﬁcant elevation in 8-isoprostane and prostaglandin metabolite levels
in the urine in obese patients. Furthermore, their results indicated that
CLA probably has a more direct effect on the non-enzymatic than on
the enzymatic conversion of AA. Risérus et al. (2004) supplemented
obese men for a period of 12 weeks with 3 g/day of CLA mixture
containing predominantly the c9,t11 isomer. Urine concentration of
8-isoprostane was 50% higher after supplementation with the CLA
isomer than the placebo, indicating that lipid oxidation is increased
not only by t10,c12, but by c9,t11 isomer as well.
However, in the present work, the animals supplemented with
CLA+P showed similar plasma 8-isoprostane levels compared to S
group. Thus, this suggests that phytosterols could counteract this
pro-oxidative effect caused by CLA consumption. Mannarino et al.
(2009) found that 6 weeks of phytosterol consumption was associated
with a signiﬁcant plasma 8-isoprostane reduction in humans,
suggesting possible antioxidative properties of phytosterols. Theseresults are consistent with our ﬁndings, since supplementation of
phytosterols prevents the increase of plasma 8-isoprostane levels
found in rats fed with CLA, and conﬁrm the beneﬁcial effect of phytos-
terols in reducing this non-enzymatic product of lipid oxidation in vivo.
However, the potential effect of daily phytosterols consumption on this
biomarker is still recent and not enough studied.
CAT and SOD are the two most important radical scavenging
enzymes and body's secondary defense against oxygen metabolites
produced due to transitional heavy metals (Nordenson & Beckman,
1981). In our data we found that a supplementation of CLA increased
the plasma CAT activity. It is known that CLA acts as a PPARα ligand
(Moya-Camarena et al., 1999), and the increase of PPARα expression
would cause higher mitochondrial and peroxisome oxidation of fatty
acids, and consequently an elevation in H2O2 production, leading to
increased CAT activity, which is observed with CLA supplementation
in this data.
However, the supplementation with CLA+P decreased the CAT
activity to basal levels when compared to S group, indicating that phy-
tosterols could be responsible for this effect. Some authors suggested
that β-sitosterol can protect against oxidative stress through modula-
tion of antioxidant enzymes and free radical production (Moreno,
2003; Vivancos &Moreno, 2005), which is consistent with our ﬁndings.
Previous studies have reported that a lower CAT activity would indicate
smaller peroxide production, which, in turn, would indicate a lower
degree of oxidative stress (Cantwell et al., 1999; Santos-Zago, Botelho,
& de Oliveira, 2007).
We did not observe any difference in GSH levels, GRd and GPx ac-
tivities among the experimental groups, although few studies have
evaluated the effect of CLA in these parameters, with contradictory
ﬁndings (Moon et al., 2009).
Lipid peroxidation is a basic cellular deteriorating process induced
by oxidative stress and occurs readily in the tissues rich in highly
oxidizable polyunsaturated fatty acids, which may lead to cell death
and disease in living organisms (Halliwell, 1994). During the process
of lipid peroxidation, hydroperoxide is produced as the ﬁrst stable
product in both the radical and non-radical reactions, and TBARS
are the secondary products, which are expressed as MDA, an indicator
of cell oxidative stress (Yamasaki et al., 2000).
With regard to effects of CLA and phytosterols on lipid peroxidation,
we found a signiﬁcant reduction in hepatic peroxide index and in
plasma and liver MDA levels, suggesting that CLA and phytosterols
could act as antioxidant agents, which is in agreement with several
studies about CLA (Ip et al., 1991; Kim et al., 2005; Moon et al., 2009;
Santos-Zago et al., 2007) and phytosterol supplementation in animal
models (Fuhrman et al., 2007; Summanen et al., 2003).
Furthermore, the association between CLA and phytosterol supple-
mentation signiﬁcantly reduced hepatic lipid peroxidation products
more than base levels, indicating that this combination potentiated
this effect in vivo, which is consistent with previous studies that
showed that plant sterols directly affect the lipid peroxidation levels
and induce a signiﬁcant reduction of these products in vitro
(Mora-Ranjeva, Charveron, Fabre, Milon, & Muller, 2006; Moreno,
2003; Vivancos & Moreno, 2005) and in vivo (Fuhrman et al., 2007;
Summanen et al., 2003). Another possible key mechanism of the pro-
tective effect exerted by phytosterols may involve the strengthening
of the intracellular antioxidant defense, which is consistent with the
decrease observed in O2− and H2O2 levels after β-sitosterol treatment
(Moreno, 2003).
Our results indicate an apparently contradictory effect by the CLA
administration related to the increase of plasma 8-isoprostane and
decrease of plasma and hepatic MDA values. These results corroborate
previously described studies of 8-isoprostane and TBARS or MDA mea-
surements in lipid peroxidation studies (Basu, 1999; Basu, Smedman, &
Vessby, 2000; Santos-Zago et al., 2007). This is possibly because these
two biomarkers reﬂect different stages of lipid peroxidation and/or in-
sufﬁcient sensitivity to detect lipid peroxidation products bymeasuring
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speciﬁc to MDA (Basu, Smedman, & Vessby, 2000; Morrow & Roberts,
1997). Other comparative in vivo studies did not show any correlation
between the increase in isoprostanes and MDA levels (Basu, 1999,
2007).
Protein oxidation and lipid peroxidation are usually interdependent
of each other in biological systems and some studies have shown a
correlation between protein oxidation and that of 8-isoprostane,
mainly owing to the different character of these oxidative processes
(Basu, 2007). It has been known that lipid peroxidation-derived reac-
tive aldehydes, such as MDA, lipid hydroperoxides and free radicals,
contribute to proteins oxidation (Popovic´, Štajner, Slavko, & Bijelic´,
2012).
Furthermore, according to the reports from Kang and Choi (2008)
CLA affects the fatty acid composition in a tissue-speciﬁc manner, in-
dicating that the metabolic rate may be slower in the liver than in the
plasma, where the plasma may respond more readily to metabolizing
the fatty acids, particularly to AA conversion.
These conﬂicting results related to lipid peroxidation indicators,
lead to the discussion that CLA supplementation inﬂuenced the process
of biological lipid oxidation in different ways, and this inﬂuence is
dependent on the autoxidation indicator used, including its tissue
and determination method. However, a mechanism that can account
for these ﬁndings cannot be readily outlined.
It is clear that the effects of CLA on oxidative stress are controversial
and not completely elucidated. There is no consensus about the real
effect of this supplement on the oxidation process of biological lipids,
since many studies show antioxidant properties and other possible
pro-oxidant effects of CLA, which corroborate our ﬁndings.
Another possible explanation for our contradictory results may be
related to the fact that the rats were not exposed to oxidative stress.
Thus, the methodology used in this study should be applied in a
future biological testing in animals exposed to a pro-oxidative agent,
and from this, protection of CLA and phytosterols against this agent
would be assessed for a longer period.
Thus, with regard to the effects of combination between CLA and
phytosterol supplementation, it could be suggested that phytosterols
could also act as antioxidant in vivo system, protecting against possible
oxidative effects of CLA supplementation, as suggested by our results.
5. Conclusion
In summary the dietary combination of CLA and phytosterols
caused improvement in antioxidant status, reduction in lipid peroxi-
dation and protects against possible effects of CLA supplementation
on oxidative stress in rats. However, metabolic effects of this associa-
tion are divergent and not completely elucidated, so further investi-
gations are needed to clarify the profound synergistic relationship
between CLA and phytosterols.
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